论文信息 - Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse. - 字舞流文

Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse.

K. Hoang-Xuan | N. Martin-Duverneuil | C. Houillier | B. Mathon | M. Le Garff-Tavernier | L. Autier

[1] V. M. de Vega,et al. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging. , 2017, Current problems in diagnostic radiology.

[2] R. Houot,et al. Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial , 2016, Neuro-oncology.

[3] K. Hoang-Xuan,et al. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients. , 2016, European journal of cancer.

[4] E. Kohmura,et al. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL). , 2012, Neuro-oncology.

[5] J. Armitage,et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.